ARTICLE | Clinical News
PTI-601: Completed Phase II study enrollment
February 26, 2001 8:00 AM UTC
Pain Therapeutics Inc. (PTIE), South San Francisco, Calif. Product: PTI-601 Business: Neurological Therapeutic category: Analgesic, Receptor antagonist Target: Opioid receptors Description: Combinatio...